Tokyo, Japan, May 30, 2006 - (JCN) - On May 29, Banyu Pharmaceutical announced that the results of its recent trial of Propecia, an agent for the treatment of androgenetic alopecia (AGA), have been published in the May 16 issue of Japanese Journal of Clinical Dermatology, an academic dermatology journal.
According to the journal, the company has confirmed the safety and efficacy of Propecia Tablet 1mg in a 3-year administration. Propecia (finasteride), which was developed by Merck & Co., is indicated for the treatment of male pattern hair loss on the vertex and anterior mid-scalp area.
Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
COPYRIGHT 2006 Gale Group
JCNN News Summaries
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment